Amgen Inc. Business Finance Contracts & Agreements
87 Contracts & Agreements
- Credit Agreements (9 contracts)
- Exchange Agreements (5)
- Guarantee Agreements (2)
- Indenture Agreements (5)
- Loan Agreements (2)
- Note Agreements (17)
- Purchase Agreements (11)
- Registration Rights Agreements (2)
- Release Agreements (1)
- Repurchase Agreements (1)
- Share Agreements (4)
- Shareholders Agreements (2)
- Stock Agreements (8)
- Underwriting Agreements (18)
- Third Amended and Restated Credit Agreement, dated as of March 9, 2023, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase... (Filed With SEC on March 9, 2023)
- Officers Certificate of the Company, dated as of March 2, 2023, including forms of the Companys 5.250% Senior Notes due 2025, 5.507% Senior Notes due 2026, 5.150% Senior Notes due... (Filed With SEC on March 2, 2023)
- Underwriting Agreement, dated February 15, 2023, by and among the Company and Citigroup Global Markets Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Mizuho Securities... (Filed With SEC on February 16, 2023)
- Amendment No. 3 to Share Purchase Agreement, dated January 30, 2023, by and among BeiGene, Ltd. and Amgen Inc (Filed With SEC on January 31, 2023)
- Term Loan Credit Agreement, dated as of December 22, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,... (Filed With SEC on December 22, 2022)
- Bridge Credit Agreement, dated as of December 12, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,... (Filed With SEC on December 12, 2022)
- Officers Certificate of the Company, dated as of August 18, 2022, including forms of the Companys 4.050% Senior Notes due 2029, 4.200% Senior Notes due 2033 and 4.875% Senior... (Filed With SEC on August 18, 2022)
- Underwriting Agreement, dated August 15, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and Deutsche Bank... (Filed With SEC on August 18, 2022)
- Officers Certificate of the Company, dated as of February 22, 2022, including forms of the Companys 3.000% Senior Notes due 2029, 3.350% Senior Notes due 2032, 4.200% Senior Notes... (Filed With SEC on February 22, 2022)
- Underwriting Agreement, dated February 17, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Goldman Sachs &... (Filed With SEC on February 22, 2022)
- Officers Certificate of the Company, dated as of August 9, 2021, including forms of the Companys 1.650% Senior Notes due 2028, 2.000% Senior Notes due 2032, 2.800% Senior Notes... (Filed With SEC on August 9, 2021)
- Underwriting Agreement, dated August 5, 2021, by and among the Company and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman Sachs & Co.... (Filed With SEC on August 9, 2021)
- Restated Amendment No. 2 to Share Purchase Agreement, dated September 24, 2020, by and among BeiGene, Ltd. and Amgen Inc (Filed With SEC on October 29, 2020)
- Registration Rights Agreement, dated as of August 17, 2020, by and among the Company, BofA Securities, Inc. and J.P. Morgan Securities LLC, as lead dealer managers, and BNP... (Filed With SEC on August 18, 2020)
- Officers Certificate of Amgen Inc., dated as of August 17, 2020, including forms of the Companys 2.770% Senior Notes due 2053 (Filed With SEC on August 18, 2020)
- Officers Certificate of the Company, dated as of May 6, 2020, including the form of the Companys 2.300% Senior Notes due 2031 (Filed With SEC on May 6, 2020)
- Underwriting Agreement, dated as of May 4, 2020, by and among the Company and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley &... (Filed With SEC on May 6, 2020)
- Amendment No. 2 to Share Purchase Agreement, dated March 17, 2020, by and among BeiGene, Ltd. and Amgen Inc (Filed With SEC on May 1, 2020)
- Officers Certificate of the Company, dated as of February 21, 2020, including forms of the Companys 1.900% Senior Notes due 2025, 2.200% Senior Notes due 2027, 2.450% Senior Notes... (Filed With SEC on February 21, 2020)
- Underwriting Agreement, dated February 18, 2020, by and among the Company and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and Morgan Stanley &... (Filed With SEC on February 21, 2020)
- Guarantee, dated as of October 31, 2019, made by and among BeiGene, Ltd. and Amgen Inc (Filed With SEC on February 12, 2020)
- Amendment No. 2 to the Asset Purchase Agreement, dated October 17, 2019, by and between Amgen Inc. and Celgene Corporation (Filed With SEC on February 12, 2020)
- Second Amended and Restated Credit Agreement, dated as of December 12, 2019, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase... (Filed With SEC on December 12, 2019)
- Amendment No. 1 to the Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation (Filed With SEC on October 18, 2019)
- Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation (Filed With SEC on August 26, 2019)
- Irrevocable Guarantee, dated August 25, 2019, by and between Amgen Inc. and Bristol-Myers Squibb Company (Filed With SEC on August 26, 2019)
- Amendment No. 1 to the Credit Agreement, dated March 9, 2018, among Amgen Inc., the Banks therein named, and Citibank, N.A., as administrative agent (Filed With SEC on April 25, 2018)
- Officers Certificate of the Company, dated as of November 2, 2017, including the form of the Companys 3.200% Senior Notes due 2027 (Filed With SEC on November 2, 2017)
- Underwriting Agreement, dated October 31, 2017, by and among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BNP Paribas Securities Corp., as... (Filed With SEC on November 2, 2017)
- AMGEN INC. $300,000,000SENIOR FLOATING RATE NOTES DUE 2019 $300,000,000 SENIOR FLOATING RATE NOTES DUE 2020 $700,000,000 1.900% SENIOR NOTES DUE 2019 $700,000,000 2.200% SENIOR... (Filed With SEC on May 11, 2017)
- Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange... (Filed With SEC on February 14, 2017)
- AMGEN INC. $750,000,0001.850% SENIOR NOTES DUE 2021 $750,000,000 2.250% SENIOR NOTES DUE 2023 $1,250,000,000 2.600% SENIOR NOTES DUE 2026 $1,000,000,000 4.400% SENIOR NOTES DUE... (Filed With SEC on August 19, 2016)
- REGISTRATION RIGHTS AGREEMENT among AMGEN INC. and CREDIT SUISSE SECURITIES(USA) LLC J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. and MIZUHO SECURITIES USA INC. each... (Filed With SEC on June 14, 2016)
- AMGENINC. 1,250,000,000 1.250% SENIOR NOTES DUE 2022 750,000,000 2.000% SENIOR NOTES DUE 2026 Underwriting Agreement (Filed With SEC on February 25, 2016)
- AMGENINC. $750,000,000 2.125% SENIOR NOTES DUE 2020 $500,000,000 2.700% SENIOR NOTES DUE 2022 $1,000,000,000 3.125% SENIOR NOTES DUE 2025 $1,250,000,000 4.400% SENIOR NOTES DUE... (Filed With SEC on May 1, 2015)
- Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange... (Filed With SEC on February 19, 2015)
- AMENDED ANDRESTATED CREDIT AGREEMENT Dated as of July 30, 2014 among Amgen Inc., The Borrowing Subsidiaries Herein Named, The Banks Herein Named, Citibank, N.A., asAdministrative... (Filed With SEC on July 30, 2014)
- AMGEN INC. INDENTURE Dated as of May 22, 2014 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee TABLE OF CONTENTS (Filed With SEC on May 22, 2014)
- AMGENINC. $850,000,000 1.250% SENIOR NOTES DUE 2017 $1,400,000,000 2.200% SENIOR NOTES DUE 2019 $1,400,000,000 3.625% SENIOR NOTES DUE 2024 $600,000,000 SENIOR FLOATING RATE NOTES... (Filed With SEC on May 22, 2014)
- AMENDMENT NO. 14 TO THE SHAREHOLDERS AGREEMENT OF KIRIN-AMGEN, INC. (Filed With SEC on April 30, 2014)
